Literature DB >> 17276010

Inhibition of PTEN and activation of Akt by menadione.

Kyoko Yoshikawa1, Kiyomi Nigorikawa, Mariko Tsukamoto, Namiko Tamura, Kaoru Hazeki, Osamu Hazeki.   

Abstract

Menadione (vitamin K(3)) has been shown to activate Erk in several cell lines. This effect has been shown to be due to the activation of EGF receptors (EGFR) as a result of inhibition of some protein tyrosine phosphatases. In the present study, we examined the effects of menadione on Akt in Chinese hamster ovary cells. The phosphorylation of Akt by menadione was not inhibited by AG1478, an inhibitor of EGFR. Menadione inhibited the lipid phosphatase activity of PTEN in a cell-free system. In an intact cell system, menadione inhibited the effect of transfected PTEN on Akt. Thus, one mechanism of its action was considered the accelerated activation of Akt through inhibition of PTEN. This was not the sole mechanism responsible for the EGFR-independent activation of Akt, because menadione attenuated the rate of Akt dephosphorylation even in PTEN-null PC3 cells. The decelerated inactivation of Akt, probably through inhibition of some tyrosine phosphatases, was considered another mechanism of its action.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17276010     DOI: 10.1016/j.bbagen.2006.12.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Novel pyrrolidine-aminophenyl-1,4-naphthoquinones: structure-related mechanisms of leukemia cell death.

Authors:  Maher Hallak; Michael Danilenko; Thida Win; Shmuel Bittner; Yosef Granot; Ofer Shpilberg; Itai Levi; Ilana Nathan
Journal:  Mol Cell Biochem       Date:  2022-07-14       Impact factor: 3.842

2.  Cell-type-specific roles of IGF-1R and EGFR in mediating Zn2+-induced ERK1/2 and PKB phosphorylation.

Authors:  Nihar R Pandey; George Vardatsikos; Mohamad Z Mehdi; Ashok K Srivastava
Journal:  J Biol Inorg Chem       Date:  2009-11-28       Impact factor: 3.358

3.  Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis.

Authors:  Meera Shah; John L Stebbins; Antimone Dewing; Jianfei Qi; Maurizio Pellecchia; Ze'ev A Ronai
Journal:  Pigment Cell Melanoma Res       Date:  2009-08-27       Impact factor: 4.693

Review 4.  Rash from EGFR inhibitors: opportunities and challenges for palliation.

Authors:  Benjamin M Solomon; Aminah Jatoi
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

5.  Administration of Menadione, Vitamin K3, Ameliorates Off-Target Effects on Corneal Epithelial Wound Healing Due to Receptor Tyrosine Kinase Inhibition.

Authors:  Jamie S Rush; David P Bingaman; Paul G Chaney; Martin B Wax; Brian P Ceresa
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-11-01       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.